SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-049075
Filing Date
2024-04-26
Accepted
2024-04-26 16:03:35
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A glue_2024_naa_card.htm DEFA14A 10793
2 GRAPHIC img62072694_0.jpg GRAPHIC 2230582
3 GRAPHIC img62072694_1.jpg GRAPHIC 160196
  Complete submission text file 0000950170-24-049075.txt   3298610
Mailing Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118
Business Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118 617-949-2643
Monte Rosa Therapeutics, Inc. (Filer) CIK: 0001826457 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40522 | Film No.: 24883476
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)